Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation
Mishra, Hemant K, Dixon, Kate J, Pore, Nabendu, Felices, Martin, Miller, Jeffrey S, Walcheck, Bruce
Published in Frontiers in immunology (22.07.2021)
Published in Frontiers in immunology (22.07.2021)
Get full text
Journal Article
Blocking ADAM17 Function with a Monoclonal Antibody Improves Sepsis Survival in a Murine Model of Polymicrobial Sepsis
Mishra, Hemant K, Ma, Jing, Mendez, Daniel, Hullsiek, Robert, Pore, Nabendu, Walcheck, Bruce
Published in International journal of molecular sciences (12.09.2020)
Published in International journal of molecular sciences (12.09.2020)
Get full text
Journal Article
EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms
PORE, Nabendu, ZIBIN JIANG, GUPTA, Anjali, CERNIGLIA, George, KAO, Gary D, MAITY, Amit
Published in Cancer research (Chicago, Ill.) (15.03.2006)
Published in Cancer research (Chicago, Ill.) (15.03.2006)
Get full text
Journal Article
Akt1 Activation Can Augment Hypoxia-Inducible Factor-1α Expression by Increasing Protein Translation through a Mammalian Target of Rapamycin–Independent Pathway
Pore, Nabendu, Jiang, Zibin, Shu, Hui-Kuo, Bernhard, Eric, Kao, Gary D., Maity, Amit
Published in Molecular cancer research (01.07.2006)
Published in Molecular cancer research (01.07.2006)
Get full text
Journal Article
Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy
Cerniglia, George J, Pore, Nabendu, Tsai, Jeff H, Schultz, Susan, Mick, Rosemarie, Choe, Regine, Xing, Xiaoman, Durduran, Turgut, Yodh, Arjun G, Evans, Sydney M, Koch, Cameron J, Hahn, Stephen M, Quon, Harry, Sehgal, Chandra M, Lee, William M F, Maity, Amit
Published in PloS one (06.08.2009)
Published in PloS one (06.08.2009)
Get full text
Journal Article
HIV Protease Inhibitors Decrease VEGF/HIF-1α Expression and Angiogenesis in Glioblastoma Cells
Pore, Nabendu, Gupta, Anjali K., Cerniglia, George J., Maity, Amit
Published in Neoplasia (New York, N.Y.) (01.11.2006)
Published in Neoplasia (New York, N.Y.) (01.11.2006)
Get full text
Journal Article
In Vivo Loss of Function Screening Reveals Carbonic Anhydrase IX as a Key Modulator of Tumor Initiating Potential in Primary Pancreatic Tumors
Pore, Nabendu, Jalla, Sanjoo, Liu, Zheng, Higgs, Brandon, Sorio, Claudio, Scarpa, Aldo, Hollingsworth, Robert, Tice, David A, Michelotti, Emil
Published in Neoplasia (New York, N.Y.) (01.06.2015)
Published in Neoplasia (New York, N.Y.) (01.06.2015)
Get full text
Journal Article
M-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivo
Curry, Jennifer M, Eubank, Tim D, Roberts, Ryan D, Wang, Yijie, Pore, Nabendu, Maity, Amit, Marsh, Clay B
Published in PloS one (14.10.2008)
Published in PloS one (14.10.2008)
Get full text
Journal Article
Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism
Pore, Nabendu, Liu, Shuang, Shu, Hui-Kuo, Li, Bin, Haas-Kogan, Daphne, Stokoe, David, Milanini-Mongiat, Julie, Pages, Gilles, O'Rourke, Donald M, Bernhard, Eric, Maity, Amit
Published in Molecular biology of the cell (01.11.2004)
Published in Molecular biology of the cell (01.11.2004)
Get full text
Journal Article
Regulation of histone deacetylase 4 expression by the SP family of transcription factors
Liu, Fang, Pore, Nabendu, Kim, Mijin, Voong, K Ranh, Dowling, Melissa, Maity, Amit, Kao, Gary D
Published in Molecular biology of the cell (01.02.2006)
Published in Molecular biology of the cell (01.02.2006)
Get full text
Journal Article
Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional STK11 Mutations in Patients with Non-Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown
Pore, Nabendu, Wu, Song, Standifer, Nathan, Jure-Kunkel, Maria, de Los Reyes, Melissa, Shrestha, Yashaswi, Halpin, Rebecca, Rothstein, Raymond, Mulgrew, Kathy, Blackmore, Stephen, Martin, Philip, Meekin, 3rd, John, Griffin, Matthew, Bisha, Ina, Proia, Theresa A, Miragaia, Ricardo J, Herbst, Ronald, Gupta, Ashok, Abdullah, Shaad E, Raja, Rajiv, Frigault, Melanie M, Barrett, J Carl, Dennis, Phillip A, Ascierto, Maria Libera, Oberst, Michael D
Published in Cancer discovery (01.11.2021)
Published in Cancer discovery (01.11.2021)
Get full text
Journal Article
Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2
Wichmann, Christian Werner, Burvenich, Ingrid Julienne Georgette, Guo, Nancy, Rigopoulos, Angela, McDonald, Alexander, Cao, Diana, O'Keefe, Graeme Joseph, Gong, Sylvia Jie, Gan, Hui Kong, Scott, Fiona Elizabeth, Pore, Nabendu, Coats, Steven, Scott, Andrew Mark
Published in Nuclear medicine and biology (01.07.2023)
Published in Nuclear medicine and biology (01.07.2023)
Get full text
Journal Article
Regulation of glut1 mRNA by Hypoxia-inducible Factor-1
Chen, Changhu, Pore, Nabendu, Behrooz, Alireza, Ismail-Beigi, Faramarz, Maity, Amit
Published in The Journal of biological chemistry (23.03.2001)
Published in The Journal of biological chemistry (23.03.2001)
Get full text
Journal Article
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma
Dimopoulos, Meletios A, Migkou, Magdalini, Bhutani, Manisha, Ailawadhi, Sikander, Kalff, Anna, Walcott, Farzana L, Pore, Nabendu, Brown, Miranda, Wang, Fujun, Cheng, Lily I, Kagiampakis, Ioannis, Williams, Marna, Kinneer, Krista, Wu, Yuling, Jiang, Yu, Kubiak, Robert J, Zonder, Jeffrey A, Larsen, Jeremy, Sirdesai, Shreerang, Yee, Andrew J, Kumar, Shaji
Published in Leukemia & lymphoma (01.12.2024)
Published in Leukemia & lymphoma (01.12.2024)
Get more information
Journal Article
Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia
Chen, C, Pore, N, Behrooz, A, Ismail-Beigi, F, Maity, A
Published in The Journal of biological chemistry (23.03.2001)
Published in The Journal of biological chemistry (23.03.2001)
Get full text
Journal Article
Abstract LB-295: MEDI7247, a novel pyrrolobenzodiazepine ADC targeting ASCT2 with potent in vivo activity across a spectrum of hematological malignancies
Monks, Noel R., Schifferli, Kevin P., Tammali, Ravinder, Borrok, M. Jack, Coats, Steven R., Herbst, Ronald, Tice, David A., Pore, Nabendu
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract LB-298: MEDI7247: A first in class antibody drug conjugate targeting ASCT2 in a range of solid tumors
Schifferli, Kevin P., Monks, Noel R., Tammali, Ravinder, Borrok, M Jack, Flynn, Matthew G., Hurt, Elaine M., Coats, Steven R., Herbst, Ronald, Tice, David A., Pore, Nabendu
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract LB-296: Discovery and development of MEDI7247, a novel Pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2, for treating hematological and solid cancers
Pore, Nabendu, Borrok, M Jack, Rebellato, Marlon, Hinrichs, MaryJane, Schifferli, Kevin P., Monks, Noel R., Tammali, Ravinder, Herbst, Ronald, Coats, Steven R., Tice, David A.
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article